• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白磷酸酶 2A 通过抑制 p53 促进二乙基亚硝胺诱导的肝癌发生。

Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53.

机构信息

Department of Biomedicine and.

出版信息

Carcinogenesis. 2014 Jan;35(1):114-22. doi: 10.1093/carcin/bgt258. Epub 2013 Jul 29.

DOI:10.1093/carcin/bgt258
PMID:23901063
Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Most HCCs develop in cirrhotic livers. Alcoholic liver disease, chronic hepatitis B and chronic hepatitis C are the most common underlying liver diseases. Hepatitis C virus (HCV)-specific mechanisms that contribute to HCC are presently unknown. Transgenic expression of HCV proteins in the mouse liver induces an overexpression of the protein phosphatase 2A catalytic subunit (PP2Ac). We have previously reported that HCV-induced PP2Ac overexpression modulates histone methylation and acetylation and inhibits DNA damage repair. In this study, we analyze tumor formation and gene expression using HCV transgenic mice that overexpress PP2Ac and liver tissues from patients with HCC. We demonstrate that PP2Ac overexpression interferes with p53-induced apoptosis. Injection of the carcinogen, diethylnitrosamine, induced significantly more and larger liver tumors in HCV transgenic mice that overexpress PP2Ac compared with control mice. In human liver biopsies from patients with HCC, PP2Ac expression was significantly higher in HCC tissue compared with non-tumorous liver tissue from the same patients. Our findings demonstrate an important role of PP2Ac overexpression in liver carcinogenesis and provide insights into the molecular pathogenesis of HCV-induced HCC.

摘要

肝细胞癌 (HCC) 是全球最常见的癌症之一。大多数 HCC 发生在肝硬化肝脏中。酒精性肝病、慢性乙型肝炎和慢性丙型肝炎是最常见的潜在肝病。目前尚不清楚导致 HCC 的 HCV 特异性机制。HCV 蛋白在小鼠肝脏中的转基因表达会导致蛋白磷酸酶 2A 催化亚基 (PP2Ac) 的过度表达。我们之前曾报道过,HCV 诱导的 PP2Ac 过度表达会调节组蛋白甲基化和乙酰化,并抑制 DNA 损伤修复。在这项研究中,我们使用过度表达 PP2Ac 的 HCV 转基因小鼠和 HCC 患者的肝组织分析肿瘤形成和基因表达。我们证明 PP2Ac 过表达会干扰 p53 诱导的细胞凋亡。与对照小鼠相比,在用致癌剂二乙基亚硝胺注射后,过度表达 PP2Ac 的 HCV 转基因小鼠中诱导出的肝肿瘤数量更多、体积更大。在 HCC 患者的肝活检组织中,与同一患者的非肿瘤性肝组织相比,PP2Ac 的表达在 HCC 组织中明显更高。我们的研究结果表明 PP2Ac 过度表达在肝癌发生中起重要作用,并为 HCV 诱导的 HCC 的分子发病机制提供了新的见解。

相似文献

1
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53.蛋白磷酸酶 2A 通过抑制 p53 促进二乙基亚硝胺诱导的肝癌发生。
Carcinogenesis. 2014 Jan;35(1):114-22. doi: 10.1093/carcin/bgt258. Epub 2013 Jul 29.
2
Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.病毒诱导的蛋白磷酸酶2A过表达抑制丙型肝炎中的胰岛素信号传导。
J Hepatol. 2008 Sep;49(3):429-40. doi: 10.1016/j.jhep.2008.04.007. Epub 2008 Apr 30.
3
Two-stage model of chemically induced hepatocellular carcinoma in mouse.小鼠化学诱导肝细胞癌的两阶段模型。
Oncol Res. 2013;20(11):517-28. doi: 10.3727/096504013X13747716581336.
4
Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.增殖标志物Ki-67和p53蛋白在HBV或HCV肝硬化中的肝脏表达与发育异常肝细胞变化及肝细胞癌的关系。
J Viral Hepat. 2005 Nov;12(6):635-41. doi: 10.1111/j.1365-2893.2005.00635.x.
5
Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma.蛋白磷酸酶2A催化亚基(PP2Ac)的上调预示着预后不良,并促进肝细胞癌的侵袭性。
Cancer Biol Ther. 2016;17(2):151-62. doi: 10.1080/15384047.2015.1121345. Epub 2015 Nov 30.
6
Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A.丙型肝炎病毒通过上调蛋白磷酸酶2A来抑制干扰素信号传导。
Gastroenterology. 2004 Jan;126(1):263-77. doi: 10.1053/j.gastro.2003.10.076.
7
The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.伴有和不伴有肝硬化的丙型肝炎病毒相关肝细胞癌中p53、c-Jun、c-Myc和p21的差异免疫组化表达
Appl Immunohistochem Mol Morphol. 2016 Feb;24(2):75-87. doi: 10.1097/PAI.0000000000000155.
8
DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.DDX3是一种DEAD盒RNA解旋酶,在肝炎病毒相关的肝细胞癌中表达失调,并参与细胞生长控制。
Oncogene. 2006 Mar 30;25(14):1991-2003. doi: 10.1038/sj.onc.1209239.
9
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.丙型肝炎病毒核心蛋白在转基因小鼠中诱发肝细胞癌。
Nat Med. 1998 Sep;4(9):1065-7. doi: 10.1038/2053.
10
Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.肝癌中 p53 诱导的抗增殖基因 BTG2 的异常表达与细胞周期相关蛋白的过度表达有关。
Cell Biochem Biophys. 2011 Sep;61(1):83-91. doi: 10.1007/s12013-011-9164-x.

引用本文的文献

1
The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells.蛋白磷酸酶-2A 亚基 PR130 参与了胰腺导管腺癌细胞中细胞毒性蛋白聚集体的形成。
Cell Commun Signal. 2024 Apr 3;22(1):217. doi: 10.1186/s12964-024-01597-8.
2
LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma.LCMT1提示预后不良,且对肝细胞癌的细胞增殖至关重要。
Transl Oncol. 2023 Jan;27:101572. doi: 10.1016/j.tranon.2022.101572. Epub 2022 Nov 16.
3
Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells.
达沙替尼联合岗田酸通过靶向蛋白磷酸酶 PP2A 诱导慢性髓系白血病细胞凋亡和细胞周期停滞。
Med Oncol. 2022 Jan 29;39(4):46. doi: 10.1007/s12032-021-01643-2.
4
The effect of expression on the prognosis of patients with hepatocellular carcinoma and its molecular biological characteristics.表达对肝细胞癌患者预后的影响及其分子生物学特征。
J Gastrointest Oncol. 2021 Dec;12(6):3008-3021. doi: 10.21037/jgo-21-720.
5
Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.蛋白磷酸酶 2A 作为小细胞肺癌的治疗靶点。
Mol Cancer Ther. 2021 Oct;20(10):1820-1835. doi: 10.1158/1535-7163.MCT-21-0013. Epub 2021 Jul 12.
6
TIPRL, a Novel Tumor Suppressor, Suppresses Cell Migration, and Invasion Through Regulating AMPK/mTOR Signaling Pathway in Gastric Cancer.TIPRL是一种新型肿瘤抑制因子,通过调节胃癌中的AMPK/mTOR信号通路来抑制细胞迁移和侵袭。
Front Oncol. 2020 Jul 3;10:1062. doi: 10.3389/fonc.2020.01062. eCollection 2020.
7
Redox inhibition of protein phosphatase PP2A: Potential implications in oncogenesis and its progression.氧化还原抑制蛋白磷酸酶 PP2A:在肿瘤发生及其进展中的潜在意义。
Redox Biol. 2019 Oct;27:101105. doi: 10.1016/j.redox.2019.101105. Epub 2019 Jan 14.
8
Inhibition of Protein Phosphatase 2A Sensitizes Mucoepidermoid Carcinoma to Chemotherapy via the PI3K-AKT Pathway in Response to Insulin Stimulus.蛋白磷酸酶2A的抑制通过PI3K-AKT途径在胰岛素刺激下使黏液表皮样癌对化疗敏感。
Cell Physiol Biochem. 2018;50(1):317-331. doi: 10.1159/000494008. Epub 2018 Oct 3.
9
KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway.KIAA1199 通过由 PP2A/微管蛋白稳定蛋白途径调控的微管不稳定促进结直肠癌细胞转移。
Oncogene. 2019 Feb;38(7):935-949. doi: 10.1038/s41388-018-0493-8. Epub 2018 Sep 10.
10
Mechanisms of hepatocarcinogenesis in chronic hepatitis C.慢性丙型肝炎中肝癌发生的机制。
Hepat Oncol. 2014 Jun;1(3):293-307. doi: 10.2217/hep.14.7. Epub 2014 Sep 9.